Evotec
Claudio Cafiero is a highly experienced professional in pharmaceutical development and manufacturing, currently serving as Senior Manager at Evotec since January 2021, overseeing the formulation project leaders group and providing scientific support for drug product formulation and manufacturing processes. Previously, Claudio held roles such as Research Leader at Evotec, Manufacturing Science & Technology Manager at Dompé, and CMC - DP Process Development & GMP Manufacturing Unit Head at Chiesi Group, where responsibilities included new product introduction, process development, and technology transfer. Claudio's academic credentials include a Certificate of Advanced Studies in Pharmaceutical Medicine from the University of Basel, a Master Degree in Chemical Engineering, and a Bachelor in Chemical Engineering from Università degli Studi di Napoli Federico II.
This person is not in any teams
This person is not in any offices
Evotec
5 followers
Evotec AG is a drug discovery and development company. The Company operates through two segments. The EVT Execute segment provides standalone drug discover services on a typical fee-for-service basis or integrated drug discovery collaborations on partners' target through a range of commercial structures, including research fees, milestones and/or royalties. The EVT Innovate segment develops drug discovery programs and assets, both internally or through academic collaborations. The Company seeks to partner these into collaborations in return for upfront payments, ongoing research payments. It consists of all partnerships derived from its internally developed assets and platforms and its participations in certain companies. It includes clinical initiations and progress of clinical pipeline within partnerships; expansion of academic BRIDGE network; research and development (R&D) progress with CureX/Target X initiatives, and focuses on induced pluripotent stem cells (iPSC) platform.